Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor
- PMID: 3647677
- DOI: 10.1016/0049-3848(87)90206-4
Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor
Abstract
Ether-linked lysophosphatidic acid was able to induce aggregation of platelets from various animals. Feline platelets were the most sensitive followed in decreasing order by human, bovine and rabbit platelets. ONO-6240 and CV-3988, which are antagonists of platelet activating factor, did not inhibit aggregation of feline platelets induced by ether-linked lysophosphatidic acid, indicating that the aggregation induced by the lysophosphatidic acid did not involve receptors for platelet activating factor. An addition of bovine serum albumin caused dose-dependent inhibitions on the aggregation of platelets by both ether-linked lysophosphatidic acid and platelet activating factor. Moreover, 0.5% bovine serum albumin reversed platelet aggregation by the active phospholipid before this aggregation reached a maximum. These results suggest that the lysophosphatidic acid exerts its stimulatory action extracellularly, probably by interacting with specific sites on the surface of platelet.
Similar articles
-
Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.Biochem J. 2002 Aug 1;365(Pt 3):617-28. doi: 10.1042/BJ20020348. Biochem J. 2002. PMID: 11982483 Free PMC article.
-
Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists.Thromb Res. 1987 Apr 1;46(1):153-61. doi: 10.1016/0049-3848(87)90215-5. Thromb Res. 1987. PMID: 3590110
-
A platelet-aggregating and hypotensive phospholipid isolated from bovine brain.J Pharm Pharmacol. 1986 Dec;38(12):878-82. doi: 10.1111/j.2042-7158.1986.tb03375.x. J Pharm Pharmacol. 1986. PMID: 2880959
-
[Antagonists of platelet activating factor].Seikagaku. 1985 Dec;57(12):1618-23. Seikagaku. 1985. PMID: 3009656 Review. Japanese. No abstract available.
-
A family of phospholipid autacoids: occurrence, metabolism and bioactions.Prog Lipid Res. 1995;34(2):151-84. doi: 10.1016/0163-7827(95)00001-g. Prog Lipid Res. 1995. PMID: 7480064 Review. No abstract available.
Cited by
-
Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.Naunyn Schmiedebergs Arch Pharmacol. 1990 Dec;342(6):713-8. doi: 10.1007/BF00175717. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2096302
-
Influence of plasma protein content and platelet number on the potency of PAF and its antagonist RP 59227 in rabbit platelet preparations.Br J Pharmacol. 1990 May;100(1):163-7. doi: 10.1111/j.1476-5381.1990.tb12070.x. Br J Pharmacol. 1990. PMID: 2372657 Free PMC article.
-
Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF.Br J Pharmacol. 1992 Sep;107(1):73-7. doi: 10.1111/j.1476-5381.1992.tb14465.x. Br J Pharmacol. 1992. PMID: 1330167 Free PMC article.
-
Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.Biochem J. 2002 Aug 1;365(Pt 3):617-28. doi: 10.1042/BJ20020348. Biochem J. 2002. PMID: 11982483 Free PMC article.
-
Albumin therapy augments the effect of thrombolysis on local vascular dynamics in a rat model of arteriolar thrombosis: a two-photon laser-scanning microscopy study.Stroke. 2008 May;39(5):1556-62. doi: 10.1161/STROKEAHA.107.502195. Epub 2008 Mar 6. Stroke. 2008. PMID: 18323493 Free PMC article.